The Role of Vitamin K on Knee Osteoarthritis Outcomes
Launched by BOSTON UNIVERSITY · Apr 24, 2024
Trial Information
Current as of July 24, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the effects of different types and amounts of vitamin K on knee osteoarthritis (OA) in older adults. Osteoarthritis is a common condition that causes pain and stiffness in the knees, and researchers want to find out if vitamin K can help improve outcomes for people with this condition. They will test two types of vitamin K—K1 and K2—at different doses to see if they can make a difference in knee health.
To be eligible for this trial, participants must be at least 60 years old and have a clinical diagnosis of knee osteoarthritis. They also need to be able to speak English. Unfortunately, those who are taking blood-thinning medications like warfarin or other similar drugs cannot participate. If you join the study, you can expect to receive vitamin K supplements and have your health monitored over time to see how it affects your knee OA. This trial is currently recruiting participants, and it aims to gather important information that could help improve treatment options for older adults with knee osteoarthritis.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • ≥60 years old
- • Clinical diagnosis of knee OA by the treating rheumatologist
- • English fluency
- Exclusion Criteria:
- • Anticoagulation use (including warfarin, dabigatran, rivaroxaban, apixaban)
About Boston University
Boston University, a leading research institution located in Boston, Massachusetts, is dedicated to advancing health sciences through innovative clinical trials and research initiatives. With a strong emphasis on interdisciplinary collaboration, the university leverages its extensive network of experts and state-of-the-art facilities to conduct rigorous clinical studies aimed at improving patient outcomes and addressing pressing health challenges. Boston University is committed to ethical research practices, patient safety, and the dissemination of findings to foster greater understanding and advancements in medical care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Boston, Massachusetts, United States
Patients applied
Trial Officials
Jean Liew, MD MS
Principal Investigator
Boston University Chobanian & Avedisian School of Medicine, Department of Rheumatology
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported